Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

© John Cairns & Fisher Studios

Today the UK funding bodies have published the results of the UK’s most recent national research assessment exercise, the Research Excellence Framework (REF) 2021.

Research from the Nuffield Department of Clinical Neurosciences was submitted to Unit of Assessment 4 (UA4) along with research from Psychiatry and Experimental Psychology. In UA4, 69% of Oxford’s submission was judged to be 4* (the highest score available, for research quality that is world-leading in terms of originality, significance, and rigour). Our results are complemented by outstanding results from the other areas of Medical Sciences.

Paul Harrison, Chair of the University of Oxford Neuroscience Committee, said:

'I am delighted with our performance in REF2021 Unit of Assessment 4 (Psychology, Psychiatry and Neuroscience), and pay tribute to all our researchers, and other staff, whose sustained efforts and excellence over the past seven years made it possible.

69% of our overall REF submission was rated as world-leading (4*). Notably, this included 100% of our research environment, reflecting the success of our scientific strategy, our support for our researchers, our infrastructure, and our collaborations and contributions to the field. This environment enabled us to carry out research of substantial impact (90% rated as 4*) and high quality (53% of outputs rated as 4*).

We are committed to maintaining our efforts and enhancing our achievements in Psychology, Psychiatry and Neuroscience. We already have exciting developments underway in terms of recruitment, investment and infrastructure, as well as strengthening our approaches to equality and diversity, access, and reproducibility.'

Read more on the University of Oxford website.

Similar stories

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Royal Academy of Engineering Research Fellowship

Dr Rezvan Farahibozorg has received one of 17 Royal Academy of Engineering Research Fellowships for 2022.

Three New Professors

Many congratulations to the following members of our Department who have been awarded the title of Professor in the recent Recognition of Distinction round.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.